Journal Menu
► ▼ Journal Menu-
- Vaccines Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Awards
Vaccines 2025 Travel Award
Dear Colleagues,
We are pleased to announce that Vaccines will be granting the Travel Award to two junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the Vaccines Editorial Board.
This award provides financial support for the winners to attend an international conference on laboratory and clinical vaccine research, utilization, and immunization to be held in 2025, in order to hold a presentation, present a poster, or both.
Candidate Requirements:
– Postdoctoral fellows or PhD students.
– Plans to attend an international conference in 2025 (oral presentation or poster).
Required Application Documents:
– Information of the conference the applicant is planning to attend and the abstract that will be submitted.
– Curriculum Vitae and list of publications.
– Justification letter describing the focus of the research (max. 800 words).
– Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/PhD student.
The winners (two awardees) will each be awarded CHF 500 and an electronic certificate.
Please submit your applications for the Vaccines 2025 Travel Award online by 01 November 2024. Prizes will be awarded at the end of January 2025 and announced on the Vaccines website.
Kind regards,
Vaccines Editorial Office
Vaccines 2024 Young Investigator Award
Dear Colleagues,
We are pleased to announce that Vaccines is now inviting nominations for the Vaccines 2024 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of laboratory and clinical vaccine research, utilization and immunization. All nominations will be assessed by an Award Evaluation Committee led by the Editor-in-Chief, Prof. Dr. Ralph A. Tripp.
The Prize
– CHF 2000;
– Option to publish one paper free of charge in Vaccines after peer review before the end of 2025;
– An electronic certificate.
Eligibility and Requirements
– Must have received their PhD no more than 10 years prior to 31 December 2024;
– Must have produced ground-breaking research and made a significant contribution to the advancement of laboratory and clinical vaccine research, utilization and immunization;
– Candidates must be nominated by senior scientists.
List of Documents for Nomination
– Detailed Curriculum Vitae, including an updated publication list and a list of the researcher’s own research grants;
– Scanned copy of doctorate certificate;
– Signed nomination letters from two established senior scientists.
Schedule
– Open for nomination: 15 April 2024
– Nomination deadline: 30 November 2024
– Winner announcement: 28 February 2025
How to Submit Nominations?
The nominations must be submitted online.
Contact
Ms. Miranda Shi
Marketing Specialist
Email: [email protected]
Closed Awards
Vaccines 2024 Best Paper Award
Dear Colleagues,
We are pleased to announce the “Vaccines 2024 Best Paper Award” for research and review articles published in Vaccines from 1 January 2022 to 31 December 2022. Two reviews and two research articles will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee led by the Editor-in-Chief, Prof. Dr. Ralph A. Tripp.
Eligibility for the Award:
– Papers published in Vaccines from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
The Prize for Each Winner:
– Two review awards: CHF 400 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Two research article awards: CHF 500 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Each winner will also receive an electronic certificate.
The winners will be announced on the journal website in March 2024.
Kind regards,
Vaccines Editorial Office
Vaccines 2024 Travel Award
Dear Colleagues,
As the Editor-in-Chief of Vaccines, I am pleased to announce the winners of the Vaccines 2024 Travel Award. The award has been granted to Dr. Xin Du, a postdoctoral researcher in Prof. Dr. George Y. Liu’s laboratory at the Department of Pediatrics, University of California San Diego, San Diego, USA; and Mr. Alessandro Pardini, a Ph.D. student in the Department of Rheumatology and Immunology, University Hospital of Bern, Bern, Switzerland.
As the awardees, they will each receive an honorarium of CHF 500, and an electronic certificate.
With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, I congratulate the winners on their accomplishments.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2023 Outstanding Reviewer Award
Dear Colleagues,
On behalf of the Editor-in-Chief, Prof. Dr. Ralph A. Tripp, we wish to acknowledge our reviewers who so generously offer their time to review the papers submitted to Vaccines by presenting an award to the reviewers who have demonstrated their dedication, professionalism, and timeliness in reviewing manuscripts for Vaccines.
What are the pre-requisites to be eligible for this award?
All of the reviewers for Vaccines in 2023 will be automatically included.
Selection Criteria:
– Number of review reports;
– The quality and timeliness of review reports.
What will the winners receive?
There will be three winners this year, and each will receive the following:
– CHF 500;
– An opportunity to publish a paper free of charge in 2024 in Vaccines after peer review;
– An electronic certificate.
When will the winners be announced?
The winners will be announced in March 2024 on the journal website.
How can I make myself eligible?
If you have not yet reviewed papers for Vaccines, but would like to do so, you can register as a reviewer at the following link: https://susy.mdpi.com/volunteer/profile/edit.
Kind regards,
Vaccines Editorial Office
Vaccines 2023 Young Investigator Award
Dear Colleagues,
We are pleased to announce that the winner of the Vaccines 2023 Young Investigator Award is Dr. Mona Omar Mohsen.
Dr. Mona Omar Mohsen is a Senior Scientist and Group Leader at the University of Bern, and her research interest is focused on cancer immunology/immunotherapy. Dr. Mona Omar Mohsen works on developing therapeutic cancer vaccines, immune-enhancers, checkpoint-inhibitors, and other immunotherapeutic approaches for different solid tumors, such as those of breast cancer, melanoma, and head/neck carcinoma. She works with viruslike nanoparticles (VLPs) as an efficient platform for vaccine development. She designs and develops universal and personalized cancer vaccines, which are of great interest. She have provided proof-of-concepts (PoCs) for effective therapeutic cancer vaccines and immune-enhancers in different preclinical murine models, which have been awarded several funding grants, allowing her to finance her own research group.
Dr. Mona Omar Mohsen also worked during her Post-Doctoral period on developing vaccines against infectious diseases such as MERS, Dengue, and SARS-CoV-2. During the COVID-19 pandemic, she was appointed Head of the corona-preclinical development team in Prof. Bachmann’s lab, where she worked with and led the group with great enthusiasm and published several papers, a number of them featuring her as a corresponding author. Please join us in congratulating Dr. Mona Omar Mohsen for her outstanding achievements.
As the awardee, Dr. Mona Omar Mohsen will receive an honorarium of CHF 2000, an offer to publish a paper, free of charge, in Vaccines after peer-review in 2024, and an e-certificate.
We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations they were presented with.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2023 Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the Vaccines 2023 Best Paper Award. All papers published in Vaccines from 1 January 2021 to 31 December 2021 were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, four winners were selected.
Two Reviews
(CHF 400 and a chance to publish a free paper in 2023 after peer review):
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
By Masaki Machida, Itaru Nakamura, Takako Kojima, Reiko Saito, Tomoki Nakaya, Tomoya Hanibuchi, Tomoko Takamiya, Yuko Odagiri, Noritoshi Fukushima, Hiroyuki Kikuchi, Shiho Amagasa, Hidehiro Watanabe and Shigeru Inoue
Vaccines 2021, 9(3), 210; https://doi.org/10.3390/vaccines9030210
Willingness to Receive COVID-19 Vaccination in Japan
By Takeshi Yoda and Hironobu Katsuyama
Vaccines 2021, 9(1), 48; https://doi.org/10.3390/vaccines9010048
Two Articles
(CHF 500 and a chance to publish a free paper in 2023 after peer review):
Nanomaterial Delivery Systems for mRNA Vaccines
By Michael D. Buschmann, Manuel J. Carrasco, Suman Alishetty, Mikell Paige, Mohamad Gabriel Alameh and Drew Weissman
Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
By Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, Dai Hai Nguyen, Ki Dong Park and Nghia P. Truong
Vaccines 2021, 9(4), 359; https://doi.org/10.3390/vaccines9040359
Please join us in congratulating the winners of the Vaccines 2023 Best Paper Award. We would also like to take this opportunity to thank all of our authors for your continued support of Vaccines.
Kind regards,
Vaccines Editorial Office
Vaccines 2023 Travel Award
Dear Colleagues,
As Editor-in-Chief of Vaccines, I am pleased to announce the winners of the Vaccines 2023 Travel Award. The award has been granted to Dr. Eduard Puente-Massaguer, a postdoctoral researcher at Icahn School of Medicine at Mount Sinai, USA, and Ms. Alexandra Dvorscek, a Ph.D. student at Monash University, Australia. As the awardees, they will each receive an honorarium of CHF 500 and an electronic certificate.
With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, I congratulate the winners on their accomplishments.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2022 Outstanding Reviewer Award
Dear Colleagues,
We are pleased to announce the winners of the Vaccines 2022 Outstanding Reviewer Award. The Vaccines Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Vaccines. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.
Dr. Christian Napoli
Department of Medical Surgical Sciences and Translational Medicine, “Sapienza” University of Rome, Rome, Italy
Research Interests: COVID-19 vaccination acceptance; COVID-19 vaccination hesitancy; lockdown; knowledge; behaviors; COVID-19; Legionella; legionellosis; migrants; migrant's health; Legionnaires’ disease; chikungunya; dengue
Prof. Dr. Federico Marchesi
Unit of Clinical Surgery, Department of Medicine and Surgery, University of Parma, Parma, Italy
Research Interests: general surgery; obesity surgery; health promotion; public health; infectious diseases and vaccines
Prof. Dr. Roger E. Thomas
School of Medicine, University of Calgary, Calgary, Canada
Research Interests: systematic reviews and meta-analyses; polypharmacy in seniors; potentially inappropriate medications; potential prescribing omissions; adverse drug events; vaccine effectiveness; increasing vaccine rates
The Prize for Each Winner:
– CHF 500;
– An opportunity to publish a paper free of charge in Vaccines in 2023 after peer review;
– A certificate.
Kind regards,
Vaccines Editorial Office
Vaccines 2022 Young Investigator Award
Dear Colleagues,
We are pleased to announce that the winner of the Vaccines 2022 Young Investigator Award is Dr. Carina Joe.
Dr. Carina Joe is a Senior Postdoctoral Research Scientist in Vaccine Development focusing on viral vector vaccines at the University of Oxford. She has been working as the lead scientist in process development for large-scale cGMP manufacturing of the Oxford/Astra Zeneca COVID-19 vaccine, which the team managed to develop in record time. Their manufacturing technology has been transferred to multiple GMP manufacturing facilities around the world, enabling clinical trials and global vaccine supply at cost to dozens of countries. As of October 2021, more than 2 billion doses of the vaccine have been administered around the world, saving millions of lives. She has been awarded the People of the Year Award 2021 in the category “Scientific Breakthrough” by Metro TV. This is an outstanding achievement in today’s competitive environment. Please join us in congratulating Dr. Carina Joe on her outstanding achievements.
As the awardee, Dr. Carina Joe will receive an honorarium of CHF 2000, an offer to publish a paper free of charge before 31 December 2023 in Vaccines after peer-review, and an electronic certificate.
We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2022 Best Paper Award
Dear colleagues,
We are pleased to announce the winners of the Vaccines 2022 Best Paper Award. All papers published in Vaccines from 1 January 2020 to 31 December 2020 were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, the four winning papers have been selected.
Two research articles (CHF 500 and a chance to publish a free paper in 2022):
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
By Ferdinand Zettl, Toni Luise Meister, Tanja Vollmer, Bastian Fischer, Jörg Steinmann, Adalbert Krawczyk, Philip V’kovski, Daniel Todt, Eike Steinmann, Stephanie Pfaender and Gert Zimmer
Vaccines 2020, 8(3), 386; https://doi.org/10.3390/vaccines8030386
Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States
By Kendall Pogue, Jamie L. Jensen, Carter K. Stancil, Daniel G. Ferguson, Savannah J. Hughes, Emily J. Mello, Ryan Burgess, Bradford K. Berges, Abraham Quaye and Brian D. Poole
Vaccines 2020, 8(4), 582; https://doi.org/10.3390/vaccines8040582
Two Reviews (CHF 400 and a chance to publish a free paper in 2022):
Recent Progress on the Versatility of Virus-Like Particles
By Ciying Qian, Xinlin Liu, Qin Xu, Zhiping Wang, Jie Chen, Tingting Li, Qingbing Zheng, Hai Yu, Ying Gu, Shaowei Li and Ningshao Xia
Vaccines 2020, 8(1), 139; https://doi.org/10.3390/vaccines8010139
COVID-19: Mechanisms of Vaccination and Immunity
By Daniel E. Speiser and Martin F. Bachmann
Vaccines 2020, 8(3), 404; https://doi.org/10.3390/vaccines8030404
On behalf of the assessment committee, I would like to congratulate the winners on their accomplishments. We would like to take this opportunity to thank all the nominated research groups of the above exceptional papers for their contributions to Vaccines and the Award Committee for voting and helping with this award.
Editor-in-Chief
Prof. Dr. Ralph A. Tripp, Vaccines
Vaccines 2022 Travel Award
Dear Colleagues,
As Editor-in-Chief of Vaccines, I am pleased to announce the winners of the Vaccines 2022 Travel Awards.
The award has been granted to Dr. Kyle O’Donnell, a postdoctoral fellow in Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; and Dr. Irene González Domínguez, a postdoctoral fellow in the Palese Laboratory, Department of Microbiology, Icahn School of Medicine at Mount Sinai, USA. The winners will each be awarded 800 CHF and a certificate.
With so many high-quality applicants, the evaluation process and final decision were incredibly challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, I would like to take this opportunity to congratulate the winners on their accomplishment.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2021 Outstanding Reviewer Award
Dear colleagues,
We are pleased to announce the winners of the Vaccines 2021 Outstanding Reviewer Award. The Vaccines Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Vaccines. It is due to their efforts that the high quality of the journal and quick turnaround is maintained.
Dr. Srinivasa Reddy Bonam
Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77550, USA
Research Interests: immunology; immunopharmacology; new drug candidates and basic biology
Dr. Giuseppe Di Martino
1. Department of Medicine and Ageing Sciences, School of Hygiene and Preventive Medicine, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy
2. Unit of Hygiene, Epidemiology and Public Health, Local Health Authority of Pescara, 65100 Pescara, Italy
Research Interests: vaccines, primary care, public health and epidemiology
Dr. Matteo Riccò
AUSL–IRCCS di Reggio Emilia, Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), Local Health Unit of Reggio Emilia, Via Amendola n. 2, I-42122 Reggio Emilia, Italy
Research Interests: infectious diseases; vaccine-preventable diseases; occupational medicine
Prizes:
Each winner will receive CHF 500 and a certificate.
Kind regards,
Vaccines Editorial Office
Vaccines 2021 Young Investigator Award
Dear Colleagues,
We are pleased to announce that the winner of the Vaccines 2021 Young Investigator Award is Dr. Nicholas M. Provine.
Dr. Nicholas M. Provine is a Postdoctoral Fellow of the Laboratory of Professor Paul Klenerman at Translational Gastroenterology Unit, University of Oxford, Oxford, UK. His primary research interest is in understanding the fundamental immune processes that regulate the immunogenicity and efficacy of vaccines. His current project is focused on understanding the function and development of a population of T cells that are abundant in human mucosal tissues and display traits characteristic of conventional T cells as well as traits of innate immune cells, such as NK cells. This cell population is defined by the expression of the molecule CD161, and these cells can make up more than 50% of the CD8+ T cells found within portions of the intestinal tract.
Dr. Provine received his PhD in 2015 and has an outstanding publication record, comprising 29 publications in peer-reviewed international journals. He is clearly a rising star in the field of vaccine biology. Please join us in congratulating Dr. Nicholas M. Provine on his outstanding contributions to the understanding of novel vaccines.
As the awardee, Dr. Provine will receive an honorarium of 2000 CHF, a chance to publish a paper free of charge in 2022 in Vaccines, and an engraved plaque.
We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, on behalf of Vaccines 2021 Young Investigator Evaluation Committee
Vaccines 2021 Travel Award
Dear Colleagues,
As Editor-in-Chief of Vaccines, I am pleased to announce the winners of the Vaccines Travel Awards for 2021.
The awards have been granted to: Dr. Hee Chun Chung, a postdoctoral senior researcher with College of Veterinary Medicine, Seoul National University, Korea; and Dr. Alejandro Marin Lopez, a postdoctoral researcher with the Department of Internal Medicine, Yale University, USA.
With so many high-quality applicants, the evaluation process and final decision were challenging. We would like to thank all the applicants for submitting their diverse and fascinating range of research topics. On behalf of the assessment committee, I congratulate the winners on their accomplishment.
Prof. Dr. Ralph A. Tripp
Editor-in-Chief, Vaccines
Vaccines 2020 Outstanding Reviewer Award
Dear colleagues,
We are pleased to announce the winners of the Vaccines 2020 Outstanding Reviewer Award. The Vaccines Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by our reviewers in checking the manuscripts submitted to Vaccines. It is because of their efforts that our journal maintains a high quality and quick turnaround time.
Prof. Dr. Jitse P. van Dijk
Department of Community and Occupational Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Research Interests: mental health; adolescents; Roma health; religiosity/spirituality and health
Prof. Dr. Sailen Barik
Independent scholar
Research Interests: respiratory syncytial virus; bioinformatics; molecular & cellular biology; virology; protein 3D structure; macromolecule
Kind regards,
Editor-in-Chief, Vaccines
Vaccines 2019 Travel Award
Dear Colleagues,
As the chair of Travel Award Evaluation Committee, I am pleased to announce the four winners of the 2019 Travel Awards sponsored by Vaccines. The awards were granted to Mr. Adam Cheng, Ph.D. student of the University of Minnesota, Dr. Carly May Bliss, postdoctoral research fellow of the Icahn School of Medicine at Mount Sinai, Mr. Joshua Gillard, Ph.D. student of Radboud University and Dr. Sasha Larsen, postdoctoral research fellow of the Infectious Disease Research Institute. The award recipients will receive 500 Swiss Francs each to support attendance at any academic conference related to vaccine studies in 2019.
The research interests of the awardees are presented below:
- Mr. Adam Cheng: the mechanism of viral reactivation and oncogenesis in immunosuppressed patients.
- Dr. Carly May Bliss: pre-clinical vaccine development for hepatitis C and influenza A, including mouse and rat models of infection, vaccination and virus challenge.
- Mr. Joshua Gillard: human innate immune response to vaccination and controlled human infection.
- Dr. Sasha Larsen: complex biological problems in the specialized fields of bacterial pathogenesis, as well as innate and adaptive immunity.
I would like to congratulate the winners and thank the selection committee for their excellent work in selecting the winners from such a large number of excellent candidate profiles.
Prof. Nirbhay Kumar
Vaccines Editorial Office
Vaccines 2018 Travel Award
Dear Colleagues,
As Evaluation Committee Chair of 2018 Vaccines Travel Awards, I am pleased toannounce the winners of the 2018 Vaccines Travel Awards.
We had many impressive applicants for this award from all over the world andchoosing was very difficult. Thanks to the Evaluation Committee’s thoroughdeliberation and reviews, the 2018 Travel Awards have been granted to Dr. Lynda Coughlan, a postdoctoral research fellow from Mount Sinai at IcahnSchool of Medicine, USA; and Mr. João Conniot, a PhD student from Universidadede Lisboa, Portugal. Please join us in congratulating them for their achievements.
Dr. Lynda Coughlan will be awarded 800 Swiss Francs towards participationat the “2nd International Meeting on Respiratory Pathogens” that will be heldon 7-9 March 2018 in Singapore. She will give an oral presentation for herwork entitled “Improving the immunogenicity of vaccine antigens delivered bynon-replicating adenoviral vectored vaccines by exosome-display”.
Mr. João Conniot will also be awarded 800 Swiss Francs towards participationat the “Frontiers in Immunomodulation and Cancer Therapy” that will be heldon 9-11 July 2018, Madrid, Spain. He will present his work entitled “DendriticCell-targeted Nano-vaccines Synergize with Immune Checkpoint Modulatorsfor Melanoma Treatment”.
Once again, we would like to thank all the applicants for participating, andacknowledge the members of the Evaluation Committee for their thoroughassessment of applicants. We are proud to support young scientists, and hopethose who weren’t chosen this time will apply for the 2019 Travel Awards.
Prof. Nirbhay Kumar
Tulane University, New Orleans, LA, USA